Vena Medical announces first Health Canada Medical Device License

Ontario Industry Updates
Written By Doriane Rey

Make it stand out

Whatever it is, the way you tell your story online can make all the difference.

Vena Medical recently announced the first Health Canada Medical Device License for their new product, the Vena Balloon Distal Access Catheter™ (BDAC). The Vena BDAC™ combines the balloon guide catheters and distal access catheters that are currently used in thrombectomy to remove clots from the brains of stroke victims.

Combining these two devices allows the clinician to get the balloon much closer to the clot, which is shown to improve key metrics like First Pass Success Rate, allowing removal of the clot on the first try and leading to significantly better patient outcomes. This also reduces the number of devices to treat each patient and therefore the cost of the procedure.

Vena Medical presented at the 2022 OBIO Investment Summit.

Doriane Rey
Previous

Hyivy Health secures $1.1 million in pre-seed funding to ease women’s pelvic health problems
Next

OBIO’s Fifth Annual Investment Summit Attracts Record Number of Global Investors